United States · FDA National Drug Code directory
Buprenorphine HCl and Naloxone HCl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-5074_ff43dbe4-d5eb-4eb9-a779-0066c59b633f
- Product NDC
- 63629-5074
- Form
- TABLET
- Composition / generic term
- Buprenorphine and Naloxone
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130222
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 42 TABLET in 1 BOTTLE (63629-5074-0) · 63629-5074-0
- 30 TABLET in 1 BOTTLE (63629-5074-1) · 63629-5074-1
- 60 TABLET in 1 BOTTLE (63629-5074-2) · 63629-5074-2
- 90 TABLET in 1 BOTTLE (63629-5074-3) · 63629-5074-3
- 120 TABLET in 1 BOTTLE (63629-5074-4) · 63629-5074-4
- 14 TABLET in 1 BOTTLE (63629-5074-5) · 63629-5074-5
- 28 TABLET in 1 BOTTLE (63629-5074-6) · 63629-5074-6
- 6 TABLET in 1 BOTTLE (63629-5074-7) · 63629-5074-7
- 10 TABLET in 1 BOTTLE (63629-5074-8) · 63629-5074-8
- 21 TABLET in 1 BOTTLE (63629-5074-9) · 63629-5074-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →